Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
Nevada Governor Joe Lombardo Named BIO’s Governor…
WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…
Learn more
BIO Supports PDUFA VIII Commitment Letter and…
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more…
Learn more
BIO Statement on Senate Reintroduction of the…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Sixth Annual BIO Patient and Health Advocacy Summit Concludes Today
October 3, 2017
The 2017 Patient and Health Advocacy Summit wrapped up today, having offered the nearly 240 patient groups, companies and organizations new ways to connect, strategize, learn and partner.  For the past six years, the BIO Patient and…
BIO to Offer Complimentary Access to One-on-One Partnering™ During J.P. Morgan Healthcare Conference (“JPM Week”)
September 28, 2017
BIO will offer complimentary access to its proprietary BIO One-on-One Partnering™ during "JPM" week January 7-11, 2018 
BIO Statement on California’s Drug Price Reporting & Transparency Bill
September 13, 2017
California Senate Bill 17 is bad for patient and does not deliver on its purported promises
FDA Commissioner, Dr. Scott Gottlieb, to Address BIO Patient and Health Advocacy Summit
September 5, 2017
The head of the United States Food and Drug Administration, Dr. Scott Gottlieb, will be the keynote speaker at the BIO Patient and Health Advocacy Summit, October 2-3 at the Mayflower Hotel in Washington, DC. The annual event brings together…
PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539
September 1, 2017
Washington, DC (September 1, 2017) – The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) today initiated litigation in the United States District Court for the District of Nevada…
BIO Asks EPA To Use a Forward-Looking Methodology in Setting Renewable Fuel Standards
August 31, 2017
BIO today submitted comments on EPA's proposed rule on the Renewable Fuel Standard Program: Standards for 2018 and Biomass-Based Diesel Volume for 2019.
BIO Statement on Nomination of Andrei Iancu to Lead U.S. Patent and Trademark Office
August 29, 2017
Washington, D.C. (August 29, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement on the nomination of Andrei Iancu to lead the U.S. Patent and Trademark Office:“BIO congratulates Mr…
BIO Applauds Signing of Food and Drug Administration Reauthorization Act (FDARA)
August 18, 2017
Enactment of FDA User Fee package important victory for patients, medical innovation
Fireside Chat Speakers, Programming Announced for 2017 BIO Investor Forum
August 15, 2017
BIO announces programming for the upcoming BIO Investor Conference Oct. 17-18 in San Francisco including Kristina Burow, Managing Director of ARCH Venture Partners and Dr. Richard Scheller, Chief Science Officer & Head of Therapeutics…
BIO: Senate Passage of FDA User Fee Package Important Victory for Patients, Medical Innovation
August 3, 2017
Washington, DC (August 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S…